Scarica l'app Stockscreener
5.43
1.31%
0.07
Dopo l'orario di chiusura:
5.37
-0.06
-1.10%
Voyager Therapeutics Inc Azioni (VYGR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
78.33%
19.52
|
90.06 | 4.614 | 4.853 | 150.48 |
Operating Expenses
|
0.83%
35.70
|
36.00 | 34.12 | 30.28 | 27.60 |
| Benefits Costs and Expenses |
6.13%
30.83
|
32.84 | 30.69 | 27.00 | 25.73 |
| Costs And Expenses |
6.13%
30.83
|
32.84 | 30.69 | 27.00 | 25.73 |
| Operating Income/Loss |
129.93%
-16.18
|
54.06 | -29.51 | -25.43 | 122.88 |
| Nonoperating Income/Loss |
54.31%
4.867
|
3.154 | 3.429 | 3.277 | 1.864 |
| Income/Loss From Continuing Operations Before Tax |
119.78%
-11.32
|
57.22 | -26.08 | -22.15 | 124.75 |
| Income Tax Expense/Benefit |
98.30%
0.014
|
0.822 | -0.177 | 0.059 | 0.704 |
| Income/Loss From Continuing Operations After Tax |
120.09%
-11.33
|
56.40 | -25.90 | -22.21 | 124.04 |
|
Net Income/Loss
|
120.09%
-11.33
|
56.40 | -25.90 | -22.21 | 124.04 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,675%
57.12
|
2.0586 | 43.86 | 43.52 | 40.63 |
| Diluted Average Shares |
2,816%
57.12
|
1.9586 | 43.86 | 43.52 | 42.16 |
| Basic Earnings Per Share |
116.26%
-0.20
|
1.23 | -0.59 | -0.51 | 3.05 |
| Diluted Earnings Per Share |
116.81%
-0.20
|
1.19 | -0.59 | -0.51 | 2.94 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):